GANX short interest
Gain Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,056,188 |
|---|---|
| Change vs prior report | 169,037 (+5.8%) |
| Change over six months | -6.9% |
| Days to cover | 5.93 (sector: 3.78) |
| Average daily volume | 515,381 |
| Rank in Healthcare | #329 of 922 by days to cover |
GANX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,056,188 | +5.8% | 5.93 | 515,381 |
| 2026-09-15 | 2,887,151 | +3.3% | 8.88 | 325,105 |
| 2026-08-31 | 2,795,819 | -5.3% | 7.65 | 365,405 |
| 2026-08-14 | 2,952,391 | -8.1% | 4.89 | 604,018 |
| 2026-07-31 | 3,213,359 | -10.4% | 6.65 | 483,103 |
| 2026-07-15 | 3,588,085 | -0.6% | 4.05 | 886,169 |
| 2026-06-30 | 3,608,175 | -6.8% | 1.81 | 1,998,057 |
| 2026-06-15 | 3,869,330 | +21.0% | 6.06 | 638,325 |
| 2026-05-29 | 3,198,541 | +1.2% | 3.86 | 829,426 |
| 2026-05-15 | 3,160,772 | -8.2% | 7.22 | 437,765 |
| 2026-04-30 | 3,442,408 | +3.3% | 6.33 | 543,759 |
| 2026-04-15 | 3,331,182 | +1.5% | 5.79 | 574,961 |
| 2026-03-31 | 3,282,560 | +14.2% | 4.03 | 814,757 |
| 2026-03-13 | 2,873,797 | -0.3% | 3.59 | 799,843 |
| 2026-02-27 | 2,883,705 | -5.1% | 4.08 | 706,150 |
| 2026-02-13 | 3,039,619 | +2.1% | 5.92 | 513,172 |
| 2026-01-30 | 2,976,352 | +19.9% | 3.74 | 795,383 |
| 2026-01-15 | 2,482,134 | -6.9% | 1.83 | 1,355,602 |
| 2025-12-31 | 2,666,410 | +28.6% | 1.00 | 2,698,186 |
| 2025-12-15 | 2,073,310 | +64.5% | 1.50 | 1,377,957 |
| 2025-11-28 | 1,260,732 | -29.2% | 1.28 | 987,113 |
| 2025-11-14 | 1,781,339 | +95.6% | 1.16 | 1,538,183 |
| 2025-10-31 | 910,705 | -28.3% | 1.37 | 664,358 |
| 2025-10-15 | 1,270,541 | +200.8% | 1.13 | 1,127,225 |
| 2025-09-30 | 422,327 | +12.0% | 1.00 | 644,834 |
import finzdata as yf
yf.Ticker("GANX").short_interest # every report since 2017
yf.Client().short_interest(["GANX"], start="2018-01-01")Healthcare short interest · GANX price history · Who owns GANX · All short interest